all

Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C.

The NLA aims to provide its members with relevant information and tools to succeed in the frequently changing healthcare landscape. View the documents below for resources provided by NLA members. Check back later to view new resources.

View the February 2020 Midwest quarterly e-newsletter by clicking here.